I’ve said it time and time again over the last couple of years, but maybe this will make you finally believe it. Glass isn’t dead, and as I told you across across several exclusive reports last year, there’s even new hardware being field tested right now.

To further prove this morning that Google’s troubled head-mounted display device isn’t done yet, Glass for Work startup Augmedix — which deploys wearable solutions for healthcare systems and hospitals — announced that it has raised $17 million in funding from five leading healthcare systems across the U.S. And CrowdOptic has announced that it has now surpassed 10,000 Glass livestreams…

expand full story

Healthcare seems to be one area in which Google Glass is just irresistibly great. Doctors, after all, aren’t unfamiliar with wearable tech to help them with their job; they already wear stethoscopes on a daily basis. Adding Glass to the mix brings new possibilities for more efficient patient care as well as a better work day for doctors, and Augmedix—one of the first Glass at Work partners—knows more about using Glass in medicine than any other company. Today, Augmedix announced that they’ve scored another $16 million in Series A funding.

expand full story

Google Glass may not have the best reputation in the workplace, but Mountain View is trying to change that. Today, the company announced its first wave of Glass at Work Certified Partners. This daring new brood looking to push Google’s wearable computer into the enterprise market include partners like APX Labs, Augmedix, CrowdOptic, GuidiGO and Wearable Intelligence.

expand full story

Image: Medical Daily

Two former Stanford University students who created a startup to help doctors use Google Glass to view and update patient records have raised $3.2M in venture capital funding, reports SFGate.

Augmedix’s founders say that physicians currently spend around a third of their time with a patient looking at a computer screen, and that using Glass instead will allow them to spend more time communicating with patients …  expand full story